BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aggarwal NR, Beaty LE, Bennett TD, Carlson NE, Ginde AA. Change in Effectiveness of Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 Outpatients During the Omicron Phase.. [DOI: 10.1101/2022.06.17.22276575] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Douin DJ, Wogu AF, Beaty LE, Carlson NE, Bennett TD, Aggarwal NR, Mayer DA, Ong TC, Russell S, Steele J, Peers JL, Molina KC, Wynia MK, Ginde AA. Association between treatment failure and hospitalization after receipt of neutralizing monoclonal antibody treatment for COVID-19 outpatients. BMC Infect Dis 2022;22:818. [DOI: 10.1186/s12879-022-07819-z] [Reference Citation Analysis]
2 Aggarwal NR, Molina KC, Beaty LE, Bennett TD, Carlson NE, Ginde AA. Real-world Use of Nirmatrelvir-Ritonavir in COVID-19 Outpatients During the Emergence of Omicron Variants BA.2/BA2.12.1.. [DOI: 10.1101/2022.09.12.22279866] [Reference Citation Analysis]
3 Cheng MM, Reyes C, Satram S, Birch H, Gibbons DC, Drysdale M, Bell CF, Suyundikov A, Ding X, Maher MC, Yeh W, Telenti A, Corey L. Real-world Effectiveness of Sotrovimab for the Early Treatment of COVID-19 During SARS-CoV-2 Delta and Omicron Waves in the United States.. [DOI: 10.1101/2022.09.07.22279497] [Reference Citation Analysis]